How to Read Liver Function Tests

Liver "function" tests mostly measure injury, not function

Standard liver chemistries are a pattern to interpret, not a diagnosis to read off. ALT and AST report leakage from injured liver cells, alkaline phosphatase and bilirubin report obstructed bile flow and clearance, and only albumin and clotting time actually gauge how well the liver is working. The 2017 American College of Gastroenterology (ACG) guideline on abnormal liver chemistries organizes the whole exercise around one question: which pattern is this, and what does it point toward. Getting that pattern right is what converts a confusing panel of numbers into a focused next step, which is why the phrase "liver function tests" is somewhat misleading from the start.

What each test actually measures

ALT and AST Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are enzymes that live inside hepatocytes. When those cells are stressed or dying, the enzymes spill into the blood, so a rise signals injury rather than lost function. ALT is relatively specific to the liver. AST also appears in muscle, heart, and red blood cells, which is why a high AST with a normal ALT often sends attention toward muscle injury or hemolysis instead of the liver. The label "function test" is a historical misnomer for these two: a hepatocyte can be leaking enzyme while the liver as an organ still does its job.

Alkaline phosphatase and bilirubin Alkaline phosphatase (ALP) lines the small bile ducts and rises when bile flow is impeded. It also comes from bone, placenta, and intestine, so an isolated ALP elevation is confirmed as hepatic with a gamma-glutamyl transferase (GGT) or a fractionated ALP before anyone blames the liver. Bilirubin is a clearance measure: the liver conjugates it and excretes it in bile. The ACG guideline notes that elevated conjugated (direct) bilirubin points toward hepatocellular disease or biliary obstruction, whereas a predominantly unconjugated rise often reflects something benign such as Gilbert syndrome or red-cell breakdown. That single distinction can separate a harmless result from one that needs imaging.

The R ratio separates the two main patterns

The most useful move in reading these panels is deciding whether the injury is hepatocellular or cholestatic. The ACG guideline formalizes this with the R ratio: R equals (ALT divided by its upper limit of normal) divided by (ALP divided by its upper limit of normal). An R above 5 defines a hepatocellular pattern, dominated by transaminase elevation. An R below 2 defines a cholestatic pattern, dominated by ALP. Values between 2 and 5 are mixed. That one calculation reorganizes the entire differential. A hepatocellular pattern pushes toward viral hepatitis, medications, alcohol, autoimmune disease, and metabolic (fatty) liver disease. A cholestatic pattern pushes toward gallstones, strictures, and bile-duct disease, usually imaged with an ultrasound early.

Why "normal" is a moving target

A normal-looking ALT can be falsely reassuring. The ACG guideline argues that a true healthy ALT sits near 29 to 33 IU/L for men and 19 to 25 IU/L for women, and it notes that reported upper limits vary from lab to lab and often sit well above that healthy band. A result printed as normal can still fall above the true healthy range and deserve a second look, particularly alongside metabolic risk factors. Reference ranges are population conveniences, not biological verdicts, and a result inside the printed range does not automatically clear the liver.

Magnitude and tempo carry information

How high, and how fast, both matter. The guideline grades transaminase elevations as borderline (under twice normal), mild (2 to 5 times), moderate (5 to 15 times), severe (above 15 times), and massive (above 10,000 IU/L). Very high, fast-moving values in the thousands narrow the field toward acute injury such as ischemia, acetaminophen toxicity, or acute viral hepatitis. The relationship between the two enzymes helps too: an AST that runs more than twice the ALT is a classic, though not exclusive, signature of alcohol-related injury, while most other chronic hepatocellular processes keep ALT at or above AST until fibrosis advances.

The tests that truly measure function

If a panel is going to reveal how the liver is performing rather than whether it is injured, three numbers do the real work: albumin, the prothrombin time or INR, and bilirubin. Albumin and clotting factors are manufactured by the liver, so low albumin or a prolonged INR reflects lost synthetic capacity, and a rising bilirubin reflects failing clearance. These are the values that track severity in established liver disease, and they explain how a person with advanced cirrhosis can have near-normal transaminases yet be genuinely sick. Injury enzymes and function markers answer different questions.

A pattern is a starting point, not an answer

Read together, these numbers sort a person into hepatocellular, cholestatic, or mixed injury, flag how severe and how acute the process looks, and separate injury from true dysfunction. None of that names a cause. The ACG guideline treats abnormal liver chemistries as a prompt for a structured evaluation built around history, risk factors, the R ratio, and targeted follow-up testing, not as a diagnosis to be acted on directly. This article is educational and is not medical advice; abnormal results should be interpreted by a clinician who knows the whole clinical picture.